These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2633197)

  • 21. [Participation of dopamine on the muscarinergic inhibitory effect of substance P on gastric myoelectric activity and motility].
    Jing H; Lin KW; Mei MH
    Sheng Li Xue Bao; 1995 Jun; 47(3):245-52. PubMed ID: 7570109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular calcium release in N1E-115 neuroblastoma cells is mediated by the M1 muscarinic receptor subtype and is antagonized by McN-A-343.
    Mathes C; Wang SS; Vargas HM; Thompson SH
    Brain Res; 1992 Jul; 585(1-2):307-10. PubMed ID: 1380873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium mobilization by muscarinic receptors in human astrocytoma cells: measurements with quin 2.
    Noronha-Blob L; Richard C; U'Prichard DC
    Biochem Biophys Res Commun; 1987 Aug; 147(1):182-8. PubMed ID: 2443130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease.
    McKinney M; Coyle JT
    Mayo Clin Proc; 1991 Dec; 66(12):1225-37. PubMed ID: 1749291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desensitisation of muscarinic receptor-mediated cyclic GMP formation by cultured nerve cells.
    Richelson E
    Nature; 1978 Mar; 272(5651):366-8. PubMed ID: 204871
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
    Aagaard P; McKinney M
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of the changes in intracellular calcium concentration on the activation of muscarinic receptors in hippocampal neurons.
    Kudo Y; Nakamura K; Sugaya K; Noguchi K; Iijima T; Ogura A
    Prog Brain Res; 1993; 98():323-31. PubMed ID: 8248522
    [No Abstract]   [Full Text] [Related]  

  • 28. Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists.
    Wallis RM
    Life Sci; 1995; 56(11-12):861-8. PubMed ID: 10188786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spasmolytic activity of Aquilariae Lignum Resinatum extract on gastrointestinal motility involves muscarinic receptors, calcium channels and NO release.
    Li H; Qu Y; Zhang J; Zhang J; Gao W
    Pharm Biol; 2018 Dec; 56(1):559-566. PubMed ID: 31070538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-dependent pirenzepine-sensitive muscarinic response in the rat hippocampal slice.
    Pitler TA; McCarren M; Alger BE
    Neurosci Lett; 1988 Aug; 91(2):177-82. PubMed ID: 2847084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
    Dawson GR; Iversen SD
    Behav Brain Res; 1993 Nov; 57(2):143-53. PubMed ID: 8117420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
    de Ponti F; Einaudi A; Cosentino M; D'Angelo L; Lecchini S; Frigo GM; Crema A
    J Pharmacol Exp Ther; 1993 Feb; 264(2):789-94. PubMed ID: 8437127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reciprocal hindlimb scratching and putative subtype-selective muscarinic agents.
    Raffa RB; Ortegón ME; Watson M
    Eur J Pharmacol; 1988 Dec; 158(3):289-92. PubMed ID: 3253103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The selectivity of the action of muscarinic agonists in vivo].
    Kosmachev AB; Kosmacheva IM; Iankhotova MV; Kuleshov VI
    Eksp Klin Farmakol; 1994; 57(2):6-8. PubMed ID: 8205054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of muscarinic receptor subtypes in rat gastric smooth muscle: effect of M3 selective antagonist on gastric motility and emptying.
    Lin S; Kajimura M; Takeuchi K; Kodaira M; Hanai H; Kaneko E
    Dig Dis Sci; 1997 May; 42(5):907-14. PubMed ID: 9149041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison between the anti-muscarinic and ganglion blocking activities of several atropine-like drugs].
    Kumada S; Ono T; Yamaguchi I; Otsuka M
    Nihon Yakurigaku Zasshi; 1970; 66(6):607-17. PubMed ID: 4395348
    [No Abstract]   [Full Text] [Related]  

  • 37. Involvement of the muscarinic receptors in the postsynaptic potentiation of neurogenic twitch contraction in the mouse vas deferens.
    Matsuno K; Mita S
    Life Sci; 1992; 50(11):799-806. PubMed ID: 1740963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype.
    Pazos A; Wiederhold KH; Palacios JM
    Eur J Pharmacol; 1986 Jun; 125(1):63-70. PubMed ID: 3732392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NGF promotes amyloid precursor protein secretion via muscarinic receptor activation.
    Haring R; Gurwitz D; Barg J; Pinkas-Kramarski R; Heldman E; Pittel Z; Danenberg HD; Wengier A; Meshulam H; Marciano D
    Biochem Biophys Res Commun; 1995 Aug; 213(1):15-23. PubMed ID: 7639729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synaptic effects of nicotinic and muscarinic agonists in the sympathetic ganglia of the frog].
    Bol'shakov VIu; Lukomskaia NIa
    Neirofiziologiia; 1988; 20(2):227-34. PubMed ID: 3260993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.